These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 91353

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Therapeutic value of intravenous diphenylhydantoin in digitalis arrhythmia].
    Magyarósi G.
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1985; 37(1):61-6. PubMed ID: 2409578
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The role of magnesium in digitalis toxicity.
    Seller RH.
    Am Heart J; 1971 Oct; 82(4):551-6. PubMed ID: 5111237
    [No Abstract] [Full Text] [Related]

  • 6. [Arrhythmia caused by digitalis and its treatment].
    Stazi C, Marasà G.
    Ann Med Nav (Roma); 1972 Oct; 77(1):51-80. PubMed ID: 4401945
    [No Abstract] [Full Text] [Related]

  • 7. [Relationship between blood serum magnesium and potassium levels in patients with right-ventricular circulatory insufficiency treated with lanatoside C, and the role of magnesium in the prevention of digitalis-induced arrhythmias].
    Smołuch R.
    Pol Tyg Lek; 1980 Nov 10; 35(45):1737-9. PubMed ID: 7220373
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Anti-arrhythmic effectiveness of allapinin in ventricular arrhythmia in patients with circulatory failure].
    Naumov VG, Blinov SI, Khodzhakuliev BG, Vangeli RS.
    Ter Arkh; 1988 Nov 10; 60(8):39-41. PubMed ID: 2465582
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Anti-arrhythmic agents in ischemic heart disease: supraventricular arrhythmias, digitalis toxicity and chronic stable ventricular ectopic beats.
    Opie LH.
    Methods Find Exp Clin Pharmacol; 1982 Nov 10; 4(1):25-35. PubMed ID: 7087606
    [Abstract] [Full Text] [Related]

  • 13. [A new method for the evaluation of the success of anti-arrhythmic drug therapy and a paradoxical drug-induced arrhythmogenic effect in individual patients].
    Andresen D, von Leitner ER, Wegscheider K, Schröder R.
    Z Kardiol; 1984 Aug 10; 73(8):492-7. PubMed ID: 6208699
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy of intravenous magnesium sulphate in supraventricular tachyarrhythmias.
    Joshi PP, Deshmukh PK, Salkar RG.
    J Assoc Physicians India; 1995 Aug 10; 43(8):529-31. PubMed ID: 8772970
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Magnesium as an anti-arrhythmic therapy principle in supraventricular and ventricular cardiac arrhythmias].
    Zehender M.
    Z Kardiol; 1996 Aug 10; 85 Suppl 6():135-45. PubMed ID: 9064958
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.